Overexpression of tau proteins antagonizes amyloid-β - Potentiated apoptosis through mitochondria - Caspase-3 pathway in n2a cells

Journal of Alzheimer's Disease

Volumn 20, Issue 1, 2010, Pages 145-157

  Wang, Ze Fen ^a   Yin, Jun ^a   Zhang, Yao ^a   Zhu, Ling Qiang ^a   Tian, Qing ^a   Wang, Xiao Chuan ^a   Li, Hong Lian ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; amyloid ; apoptosis; hyperphosphorylation; mitochondria; tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CYTOCHROME C; HYDROGEN PEROXIDE; PROTEIN BAX; PROTEIN BCL 2; TAU PROTEIN;

APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 77954467417     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1351     Document Type: Article

References (48)

1. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
2. Anandatheerthavarada HK, Devi L (2007) Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 13, 626-638.
3. Leuner K, Pantel J, Frey C, Schindowski K, Schulz K, Wegat T, Maurer K, Eckert A, Muller WE (2007) Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J Neural Transm Suppl, 207-215.
4. Slater AF, Stefan C, Nobel I, Van Den Dobbelsteen DJ, Orrenius S (1995) Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett 82-83, 149-153.
5. Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M, Thompson CB (2000) Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA 97, 4666-4671.
6. Sas K, Robotka H, Toldi J, Vecsei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257, 221-239.
7. Braak H, Braak E (1996) Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 165, 3-12. (Pubitemid 26143161)
8. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87, 554-567.
9. Perry G, Nunomura A, Smith MA (1998) A suicide note from Alzheimer disease neurons? Nat Med 4, 897-898.
10. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17, 2653-2657.
11. Tsang SY, Tam SC, Bremner I, Burkitt MJ (1996) Research communication copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical. Biochem J 317 (Pt 1), 13-16.
12. Su JH, Deng G, Cotman CW (1997) Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 774, 193-199.
13. Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57, 456-464.
14. Bancher C, Lassmann H, Breitschopf H, Jellinger KA (1997) Mechanisms of cell death in Alzheimer's disease. J Neural Transm Suppl 50, 141-152.
15. Perry G, Nunomura A, Lucassen P, Lassmann H, Smith MA (1998) Apoptosis and Alzheimer's disease. Science 282, 1268-1269.
16. Perry G, Zhu X, Smith MA (2001) Do neurons have a choice in death? Am J Pathol 158, 1-2.
17. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, Boux H, Castellani RJ, Perry G, SmithMA(2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 101, 305-310.
18. Raina AK, Hochman A, Ickes H, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA (2003) Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? Prog Neuropsychopharmacol Biol Psychiatry 27, 251-254.
19. Zhao Z, Ho L, Suh J, QinW, Pyo H, Pompl P, Ksiezak-Reding H, Pasinetti GM (2003) A role of P301L tau mutant in antiapoptotic gene expression, cell cycle and apoptosis. Mol Cell Neurosci 24, 367-379.
20. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22, 9340-9351.
21. Esclaire F, Terro F, Yardin C, Hugon J (1998) Neuronal apoptosis is associated with a decrease in tau mRNA expression. Neuroreport 9, 1173-1177.
22. Lesort M, Blanchard C, Yardin C, Esclaire F, Hugon J (1997) Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Brain Res Mol Brain Res 45, 127-132.
23. Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, Tian Q, Wang XC, Chen XQ, Yang Y, Zhang JY, Wang Q, Xu H, Liao FF, Wang JZ (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci USA 104, 3591-3596.
24. Famer D, Crisby M (2004) Rosuvastatin reduces caspase-3 activity and up-regulates alpha-secretase in human neuroblastoma SH-SY5Y cells exposed to A beta. Neurosci Lett 371, 209-214.
25. Jang JH, Surh YJ (2004) Bcl-2 protects against Abeta(25-35)- induced oxidative PC12 cell death by potentiation of antioxidant capacity. Biochem Biophys Res Commun 320, 880-886.
26. Watson K, Fan GH (2005) Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67, 757-765.
27. Yao M, Nguyen TV, Pike CJ (2005) Beta-amyloidinduced neuronal apoptosis involves c-Jun N-terminal kinasedependent downregulation of Bcl-w. J Neurosci 25, 1149-1158.
28. Ankarcrona M, Winblad B (2005) Biomarkers for apoptosis in Alzheimer's disease. Int J Geriatr Psychiatry 20, 101-105.
29. Lovell MA, Markesbery WR (2006) Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Curr Alzheimer Res 3, 359-364.
30. Lucassen PJ (2000) Presenilins and cellular damage: a link through amyloid? J Alzheimers Dis 2, 61-67.
31. Guo Q, Sebastian L, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999) Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J Neurochem 72, 1019-1029.
32. Cotman CW, Su JH (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6, 493-506.
33. Wang YP, Wang ZF, Zhang YC, Tian Q, Wang JZ (2004) Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability. Cell Res 14, 467-472.
34. Yamamoto T, Yuyama K, Nakamura K, Kato T, Yamamoto H (2000) Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release. Eur J Pharmacol 397, 25-33.
35. Kwon TK (2001) Phorbol myristate acetate inhibits okadaic acid-induced apoptosis and downregulation of X-linked inhibitor of apoptosis in U937 cells. Biochem Biophys Res Commun 287, 135-141.
36. Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, Eckert A (2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278, 28294-28302.
37. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 93, 953-962.
38. Marlatt M, Lee HG, Perry G, Smith MA, Zhu X (2004) Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. Acta Neurobiol Exp (Wars) 64, 81-87. (Pubitemid 38453808)
39. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L (2005) Oxidative modifications and aggregation of Cu,Znsuperoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280, 11648-11655.
40. Bouillet P, Strasser A (2002) BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 115, 1567-1574.
41. Hacker G, Weber A (2007) BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys 462, 150-155.
42. Gorman AM, Ceccatelli S, Orrenius S (2000) Role of mitochondria in neuronal apoptosis. Dev Neurosci 22, 348-358.
43. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis - the p53 network. J Cell Sci 116, 4077-4085.
44. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351, 80-84.
45. Saragoni L, Hernandez P, Maccioni RB (2000) Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells. Neurochem Res 25, 59-70.
46. Alonso AD, Grundke-Iqbal I, Barra HS, IqbalK(1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubuleassociated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94, 298-303.
47. Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91, 5562-5566.
48. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051-1063.